Thor Medical ASA: Notification of trade for close associate of primary insider

20.12.2024 15:06:52 CET | Thor Medical ASA | Mandatory notification of trade primary insiders Oslo, Norway, 20 December 2024: Scatec Innovation AS, a close associate of board member of Thor Medical ASA John Andersen, has today acquired 1,584,324 shares in Thor Medical ASA from its controlled subsidiary, Scatec Invest II AS, also a close associate of John Andersen, with a price of NOK 2.72 per share, reflecting the last 3 days' vwap for the share. The transaction is an internal group transaction to settle balances between the parent company and its subsidiary. Primary insider notifications pursuant to the market abuse regulation article 19 are attached. This information is subject to disclosure requirements pursuant to the EU Market Abuse Regulation article 5 and the Norwegian Securities Trading Act section 5-12. Contacts Gisle Bjørnstad, CFO, Scatec Innovation AS, +47 95142892, gisle.bjornstad@scatec.no ABOUT THOR MEDICAL ASA Thor Medical is an emerging supplier of radionuclides, primarily alpha particle emitters, from naturally occurring thorium. Its proprietary production process requires no irradiation or use of nuclear reactors, and provides reliable, environmentally friendly, cost-efficient supply of alpha-emitters for the radiopharmaceutical industry. Thor Medical is headquartered in Oslo, Norway and listed on the Oslo Stock Exchange under the ticker symbol 'TRMED'. To learn more, visit www.thormedical.no - http://www.thormedical.no - https://www.thormedical.no. ATTACHMENTS Download announcement as PDF.pdf - https://kommunikasjon.ntb.no/ir-files/17848634/18370282/5453/Download%20announce ment%20as%20PDF.pdf 20241220 - MAR Form - Scatec Invest II AS to Scatec Innovation AS.pdf - https://kommunikasjon.ntb.no/ir-files/17848634/18370282/5452/20241220%20-%20MAR% 20Form%20-%20Scatec%20Invest%20II%20AS%20to%20Scatec%20Innovation%20AS.pdf